Pesticide Details

289 - Imazethapyr

Functional Classes

Table Items Commodities MRL Year Symbols Notes
Table Item Maize 0.1 mg/Kg 2017 (*)
Table Item Rice 0.1 mg/Kg 2017 (*)
Table Item Lentil (dry) 0.1 mg/Kg 2017 (*)
Table Item Soya bean (dry) 0.03 mg/Kg 2017
Table Item Rape seed 0.1 mg/Kg 2017 (*)
Table Item Peanut 0.1 mg/Kg 2017 (*)
Table Item Mammalian fats (except milk fats) (group) 0.01 mg/Kg 2017 (*)
Table Item Milks (group) 0.01 mg/Kg 2017 (*)
Table Item Muscle (from mammals other than marine mammals) (group) 0.01 mg/Kg 2017 (*) The MRL refers to “meat” for which the portion of the commodity to which the MRL applies, and which is analysed, is the whole commodity (without bones). For fat-soluble pesticides, a portion of the adhering fat is analysed, and MRLs apply to the fat.
Table Item Edible offal (mammalian) (group) 0.01 mg/Kg 2017 (*)
Table Item Avian, edible offal of (group) 0.01 mg/Kg 2017 (*)
Table Item Eggs (group) 0.01 mg/Kg 2017 (*)
Table Item Avian fats (group) 0.01 mg/Kg 2017 (*)
Table Item Avian muscle (group) 0.01 mg/Kg 2017 (*) The MRL refers to “meat” for which the portion of the commodity to which the MRL applies, and which is analysed, is the whole commodity (without bones). For fat-soluble pesticides, a portion of the adhering fat is analysed, and MRLs apply to the fat.
Table Item Clover, hay and/or straw 1.5 mg/Kg 2017 (dw)
Table Item Maize fodder (dry) 0.1 mg/Kg 2017 (dw) (*)
Table Item Rice, hay and/or straw 0.15 mg/Kg 2017 (dw) (*)
(*): At or about the limit of determination.

JMPR-related informations

ADI/PTDI 0-0.6 mg/kg bw (2016)
Residue definition: For compliance with MRLs for plant commodities and for compliance with MRLs and dietary risk assessment for animal commodities: Sum of imazethapyr, 5-hydroxyethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid, expressed as imazethapyr. For dietary risk assessment) for plant commodities: Sum of imazethapyr, and 5-hydroxyethyl-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid (OH-imazethapyr), and 5-[1-(beta-D-glucopyranozyloxyethyl)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)nicotinic acid, expressed as imazethapyr. The residue is not fat soluble.